The influence of phospho-tau on dendritic spines of cortical pyramidal neurons in patients with Alzheimer’s disease
Open accessAbstract
The dendritic spines on pyramidal cells represent the main postsynaptic elements of cortical excitatory synapses and they are fundamental structures in memory, learning and cognition. In the present study, we used intracellular injections of Lucifer yellow in fixed tissue to analyse over 19 500 dendritic spines that were completely reconstructed in three dimensions along the length of the basal dendrites of pyramidal neurons in the parahippocampal cortex and CA1 of patients with Alzheimer's disease. Following intracellular injection, sections were immunostained for anti-Lucifer yellow and with tau monoclonal antibodies AT8 and PHF-1, which recognize tau phosphorylated at Ser202/Thr205 and at Ser396/404, respectively. We observed that the diffuse accumulation of phospho-tau in a putative pre-tangle state did not induce changes in the dendrites of pyramidal neurons, whereas the presence of tau aggregates forming intraneuronal neurofibrillary tangles was associated with progressive alteration of dendritic spines (loss of dendritic spines and changes in their morphology) and dendrite atrophy, depending on the degree of tangle development. Thus, the presence of phospho-tau in neurons does not necessarily mean that they suffer severe and irreversible effects as thought previously but rather, the characteristic cognitive impairment in Alzheimer's disease is likely to depend on the relative number of neurons that have well developed tangles.
AI snapshot
Written from the paper’s full text.
TL;DR
In human Alzheimer’s disease tissue, diffuse phospho-tau in a putative pre-tangle state did not alter dendritic spine or dendrite morphology, whereas tau aggregates forming neurofibrillary tangles were associated with progressive spine loss, smaller/shorter spines, and dendrite atrophy. The authors conclude that phospho-tau presence alone does not necessarily cause severe irreversible damage; cognitive impairment may depend on the relative number of neurons with well-developed tangles.
Key findings
- Across 42 Lucifer yellow-injected neurons and 19,569 dendritic spines, neurons with Pattern I diffuse phospho-tau showed no significant differences from PHF-tau− neurons in dendrite diameter, spine density, spine length, or spine volume in parahippocampal cortex Patient P9.
- In CA1 Pattern IIa neurons, changes varied by patient: Patient P9 had 22% smaller average dendrite diameter and 14% shorter average spine length; Patients P13 and P14 showed lower dendritic spine density in medial/distal dendrites; all three patients showed a higher frequency of small spines in PHF-tau+ neurons.
- Pattern IIb neurons with well-developed tangles had reduced dendritic arbors, remarkably thin dendrites, and few or virtually no dendritic spines.
- Distal dendritic segments with fibrillar PHF-tauAT8 had significantly lower spine density than adjacent pre-terminal segments lacking PHF-tauAT8, suggesting a local toxic effect.
Methods
- Human autopsy brain tissue from n = 5 patients; quantitative morphometry focused on Patients P9, P13, and P14, with neurons in layer III of parahippocampal cortex and CA1 pyramidal layer.
- Individual pyramidal cells were injected intracellularly with Lucifer yellow in fixed tissue, then sections were immunostained for anti-Lucifer yellow and tau antibodies AT8 (Ser202/Thr205) and PHF-1 (Ser396/404); spines were scanned by confocal microscopy and reconstructed in three dimensions.
- Measured dendrite diameter, dendritic spine density, spine length, and spine volume; statistics used Mann-Whitney tests, Kolmogorov-Smirnov tests for frequency distributions, and two-way ANOVA with Bonferroni post hoc comparisons for distance-from-soma analyses.
Limitations
- The paper states that relatively few cells can be injected, pyramidal cell structure differs by cortical region, human pathological tissue has high interindividual variability, the proportion of cells with neurofibrillar pathology is unpredictable before injection, and both AT8 and PHF-1 antibodies were mouse-produced so double labeling could reflect cross-reactivity.
- The paper notes uncertainty about whether Pattern I represents a pre-tangle stage preceding Pattern II or an independent subpopulation, and it cannot determine whether findings generalize to neurons with other phosphorylated tau epitopes.
- Evident from the text: the quantitative sample is small and drawn from only three patients, the design is cross-sectional autopsy tissue, and the study cannot establish causality or track progression within individual neurons over time.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
25 of 62 cited sources checked · 8 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Expression of mutant tau in mouse models of Alzheimer's disease-like tau neuropathologies can result in a significant loss of dendritic spines and synapses.
“Significantly, the expression of mutant tau in mouse models of Alzheimer’s disease-like tau neuropathologies can result in a significant loss of dendritic spines and synapses (Mocanu et al., 2008; Bittner et al., 2010; Rocher et al., 2010).”
Quote in the paperSubstantial claim2 of 3 sources checked- cites Mocanu et al., 2008 source
- cites Bittner et al., 2010 source
The Results identify a mutant tau transgene (tauP301L) in the 3xTg-AD mice and report significantly reduced dendritic spine density; the Introduction treats spines as indicators of excitatory synapses. But the Discussion associates spine loss with Aβ alone or with Aβ and hyperphosphorylated tau together. The paper does not establish that expression of mutant tau itself caused the loss. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Rocher et al., 2010 source
The Results section ('Significant reduction in dendritic spine density in TG cells'; page unavailable) reports 29% and 38% reductions in spine density in mutant-tau mice. The Discussion ('Dramatic and uniform decrease in spine density in TG cells'; page unavailable) also mentions reduced synaptophysin labeling in another mutant-tau mouse model, but this paper does not establish a significant loss of synapses in its own mice. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
There is only a weak correlation between the degree of cognitive impairment and the presence of plaques or neurofibrillary tangles.
“However, there is only a weak correlation between the degree of cognitive impairment and the presence of plaques or neurofibrillary tangles (Price et al., 2009)”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Price et al., 2009 source
The Results (Quantitative Neuropathological Assessment; page unavailable) report correlations between plaque or tangle measures and cognitive test scores, some modest in size. But the participants had no individually measurable cognitive impairment, so the study does not establish a weak correlation between lesion presence and the degree of clinical impairment. Its explicitly described “weak” correlation is between plaque burden and tangle density, not between lesions and cognition. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
The area of the postsynaptic density is proportional to the number of postsynaptic receptors.
“The area of the postsynaptic density is proportional to the number of postsynaptic receptors (Nusser et al., 1998), while the number of vesicles adjacent to the presynaptic cleft is proportional to those primed for synaptic transmitter release (Dobrunz and Stevens, 1997).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Nusser et al., 1998 source
The indexed Introduction passages (page unavailable) report a positive correlation between synapse size and AMPA-receptor immunogold labeling in the hippocampal synapses studied. The citing sentence states an unqualified proportional relationship for postsynaptic receptors generally, whereas the paper concerns AMPA receptors and notes that receptor density varies more at some spine synapses. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
The volume of the dendritic spine head is directly proportional to the strength of synaptic currents.
“Furthermore, the volume of the head is directly proportional to the strength of synaptic currents (Harris and Stevens, 1989; Schikorski and Stevens, 1997; Arellano et al., 2007a).”
Quote in the paperSubstantial claim2 of 3 sources checked- cites Harris and Stevens, 1989 source
The Discussion reports that spine-head dimensions are proportional to postsynaptic density area and presynaptic vesicle number. In “Relationships between hippocampal spine geometry and anatomical indicators of synaptic efficacy” (page not specified), the authors propose that head size might reflect synaptic efficacy. They do not establish that head volume is directly proportional to synaptic current strength; the paper says measurement of conductance at individual spine synapses was impossible. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites Schikorski and Stevens, 1997 source
The Analysis section (page unavailable) says spine-head volumes were measured, but the passages found do not relate them to synaptic-current strength. Brain active zones (page unavailable) reports a linear relationship between presynaptic bouton volume and active-zone area instead. Searches for spine-head volume, synaptic currents, and quantal amplitude did not locate the claimed proportionality. (LLM, conf=0.73)
Experimental — accuracy not yet measured - cites Arellano et al., 2007a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
The number of vesicles adjacent to the presynaptic cleft is proportional to those primed for synaptic transmitter release.
“The area of the postsynaptic density is proportional to the number of postsynaptic receptors (Nusser et al., 1998), while the number of vesicles adjacent to the presynaptic cleft is proportional to those primed for synaptic transmitter release (Dobrunz and Stevens, 1997).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Dobrunz and Stevens, 1997 source
The passage on the physical interpretation of the readily releasable pool (indexed as Abstract; no page given) says that this pool may correspond roughly to morphologically docked vesicles. It explicitly says that identifying the two pools is “far from established” and calls for a demonstration that their sizes vary correspondingly. Thus, it supports a possible relationship, not the claimed proportionality as a settled fact. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Findingown data
In Patient P9, the average dendrite diameter of PHF-tau+ neurons was 22% smaller than in PHF-tau− neurons.
“In Patient P9, the average dendrite diameter did differ significantly between the two groups of neurons, the dendrites of PHF-tau+ neurons having a 22% smaller diameter than in PHF-tau− neurons (Supplementary Fig. 7B and Supplementary Table 2).”
Quote in the paperNot a substantial claim - Findingown data
The phospho-tau neurofibrillar pathology was stronger in the CA1 than in the parahippocampal cortex from Patient P9.
“The phospho-tau neurofibrillar pathology was stronger in the CA1 than in the parahippocampal cortex from Patient P9 (Fig. 2).”
Quote in the paperNot a substantial claim - Findingown data
The diffuse accumulation of phospho-tau in a putative pre-tangle state (Pattern I) did not induce changes in the dendrites of pyramidal neurons.
“In summary, all the morphological parameters of dendrites from Lucifer yellow-injected PHF-tau+ (Pattern I) pyramidal neurons in layer III of the parahippocampal cortex remained unchanged when they were compared with the dendrites of Lucifer yellow-injected pyramidal neurons that were PHF-tau− in the same cortical area.”
- Also stated in: § Discussion · plain
“In the present study, we found no significant changes in the microanatomy of dendrites from pyramidal neurons at early stages of a neurofibrillar pathology, as defined by the presence of diffuse phospho-tau in a putative pre-tangle state (Pattern I).”
Quote in the paperSubstantial claim - Also stated in: § Discussion · plain
- Findingown data
In distal dendritic regions with fibrillar PHF-tauAT8, there was a significantly lower density of dendritic spines than in adjacent pre-terminal segments lacking PHF-tauAT8.
“When these segments were compared with adjacent segments of the same length (pre-terminal segments lacking PHF-tauAT8) there was a significantly lower density of dendritic spines in the distal dendritic regions with fibrillar PHF-tauAT8 (Supplementary Fig. 9) than in the pre-terminal segments.”
Quote in the paperSubstantial claim - Findingown data
In the CA1 region of all three patients, the neuropathological alterations were greater in Patient P14, followed by Patient P13 and then Patient P9.
“Moreover, when comparing the total neuronal density with the density of PHF-tauAT8-ir and PHF-tauPHF-1-ir neurons, and the density of amyloid-β plaques, in the CA1 region of all three patients, it seems clear that the neuropathological alterations were greater in Patient P14, followed by Patient P13 and then Patient P9.”
Quote in the paperNot a substantial claim - Findingown data
The presence of tau aggregates forming intraneuronal neurofibrillary tangles is associated with progressive alteration of dendritic spines (loss of dendritic spines and changes in their morphology) and dendrite atrophy, depending on the degree of tangle development.
“whereas the presence of tau aggregates forming intraneuronal neurofibrillary tangles was associated with progressive alteration of dendritic spines (loss of dendritic spines and changes in their morphology) and dendrite atrophy, depending on the degree of tangle development.”
- Also stated in: § Lucifer yellow-injected neurons with Pattern IIa of immunostaining for paired helical filament-tau · plain
“The presence of tau aggregates forming intraneuronal neurofibrillary tangles in these neurons gives rise to changes in the morphology of dendritic spines (smaller volume and shorter length) in all patients, although dendritic spines were only lost in Patients P13 and P14.”
- Also stated in: § Discussion · plain
“However, once tau aggregates of neurofibrillary tangles had formed (Patterns IIa and IIb), representing more advanced neurofibrillar alterations, significant reductions in the diameter of dendrites and in the number, length and volume of spines were evident.”
Quote in the paperSubstantial claim - Also stated in: § Lucifer yellow-injected neurons with Pattern IIa of immunostaining for paired helical filament-tau · plain
- Findingown data
The density of neurons in the CA3 was lower in Patients P13 and P14 than in Patient P9 (38% and 42% fewer neurons, respectively).
“However, the density of neurons in the CA3 was lower in these latter patients than in Patient P9 (38% and 42% fewer neurons, respectively), suggesting that the CA3 pathology was more advanced in these patients than in Patient P9 (Supplementary material).”
Quote in the paperSubstantial claim - Findingown data
Several significant alterations were found in neurons showing Pattern II.
“As summarized in Fig. 9, no changes were found in the number, length or volume of the dendritic spines in neurons with Pattern I, nor in dendrite diameter, whereas several significant alterations were found in neurons showing Pattern II.”
Quote in the paperSubstantial claim - Findingown data
At the intermediate level of a neurofibrillar pathology (Pattern IIa), Patient P9 showed a reduction in dendritic spine volume and length.
“At the intermediate level of a neurofibrillar pathology (Pattern IIa), we found different morphological alterations depending on the patients, mostly a reduction in dendritic spine volume and length (Patient P9) and a reduction in dendritic spine density (Patients P13 and P14).”
Quote in the paperNot a substantial claim - Findingown data
The most prominent staining of neurons with neurofibrillary tangles was observed with the PHF-1 antibody.
“However, the most prominent staining of neurons with neurofibrillary tangles was observed with the PHF-1 antibody.”
Quote in the paperNot a substantial claim - Findingown data
Neurons with well-developed neurofibrillary tangles (Pattern IIb) had a relatively small dendritic tree, with thin dendrites and very few or no spines, regardless of whether they were PHF-tauAT8-ir or PHF-tauPHF-1-ir.
“Certainly, neurons with well-developed neurofibrillary tangles (Pattern IIb) had a relatively small dendritic tree, with thin dendrites and very few or no spines, regardless of whether they were PHF-tauAT8-ir or PHF-tauPHF-1-ir.”
Quote in the paperSubstantial claim - Findingown data
At Pattern IIa, Patients P13 and P14 showed a reduction in dendritic spine density.
“At the intermediate level of a neurofibrillar pathology (Pattern IIa), we found different morphological alterations depending on the patients, mostly a reduction in dendritic spine volume and length (Patient P9) and a reduction in dendritic spine density (Patients P13 and P14).”
Quote in the paperNot a substantial claim - Findingown data
A reduction in the density of dendritic spines in the distal segments commonly accompanied the accumulation of fibrillar phospho-tauAT8.
“Here, a reduction in the density of dendritic spines in the distal segments commonly accompanied the accumulation of fibrillar phospho-tauAT8.”
Quote in the paperSubstantial claim - Findingown data
There was a decrease in the dendrite diameter in PHF-tau+ neurons showing Patterns IIa and IIb.
“There was a decrease in the dendrite diameter in PHF-tau+ neurons showing Patterns IIa and IIb, although we do not know if this reduction selectively affects some organelles or if it only represents a decrease in cytosolic volume.”
Quote in the paperSubstantial claim - Findingcitation
The vast majority of PHF-tauPHF-1-ir neurons had a large amount of aggregated tau.
“Indeed, the vast majority of PHF-tauPHF-1-ir neurons had a large amount of aggregated tau, consistent with the hypothesis that PHF-tauAT8 mostly labels the initial stages of a neurofibrillar pathology, while PHF-tauPHF-1 recognizes the later stages (Blazquez-Llorca et al., 2011).”
Quote in the paperNot a substantial claim - Findingown data
At late stages (Pattern IIb), there was a dramatic loss of spines, even in the proximal portion of the dendrites.
“At late stages (Pattern IIb), there was a dramatic loss of spines, even in the proximal portion of the dendrites.”
Quote in the paperSubstantial claim - Findingown data
Neurons with Pattern I displayed some positivity with thioflavin S.
“Neurons with Patten I displayed some positivity with thioflavin S (Fig. 3).”
Quote in the paperNot a substantial claim - Interpretationreasoning
The CA3 pathology was more advanced in Patients P13 and P14 than in Patient P9.
“suggesting that the CA3 pathology was more advanced in these patients than in Patient P9 (Supplementary material).”
Quote in the paperSubstantial claim- Rests on an assumption: Lower density of neurons in CA3 indicates more advanced CA3 pathology.
- Interpretationreasoning
The severity of these changes seems to be progressive, from the intermediate/advanced stages (Pattern IIa) to extreme stage (Pattern IIb) of the neurofibrillar pathology.
“The severity of these changes seems to be progressive, from the intermediate/advanced stages (Pattern IIa) to extreme stage (Pattern IIb) of the neurofibrillar pathology.”
Quote in the paperSubstantial claim - Premisecitation
Pattern I neurons have diffuse cytoplasmic staining, independent of the presence of some small fibrillar aggregates (putative pre-tangle stage) that may be thioflavin S positive.
“Neurons with Pattern I have diffuse cytoplasmic staining, independent of the presence of some small fibrillar aggregates (putative pre-tangle stage) that may be thioflavin S positive.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Blazquez-Llorca et al., 2010
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Study design and conductreasoning
The conditions to perform a detailed quantitative study (sufficient cells with and without neurofibrillar pathology in different regions of the same patient) were met in Patients P9, P13 and P14.
“These conditions were met in Patients P9, P13 and P14.”
Quote in the paperSubstantial claim - Interpretationreasoning
Neurons in the human brain that are recognized by PHF-tauAT8 and PHF-tauPHF-1 have not necessarily suffered severe and irreversible effects.
“In conclusion, neurons in the human brain that are recognized by PHF-tauAT8 and PHF-tauPHF-1 have not necessarily suffered severe and irreversible effects but rather, the characteristic cognitive impairment in Alzheimer’s disease is likely to depend on the relative number of neurons that are in intermediate and advanced stages of a neurofibrillar pathology, among other factors.”
Quote in the paperSubstantial claim - Interpretationreasoning
Such processes begin with synaptic disconnection of the dendritic regions distal to the soma.
“Thus, if we assume the widely accepted hypothesis that neuronal degeneration and atrophy is progressive, our observations suggest that such processes begin with synaptic disconnection of the dendritic regions distal to the soma.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Neuronal degeneration and atrophy is progressive.
- Interpretationreasoning
Pattern I is considered a putative pre-tangle stage despite some small intracellular thioflavin S positive inclusions.
“For these reasons we considered Pattern I as a putative pre-tangle stage in spite of the fact that these neurons may show some small intracellular thioflavin S positive inclusions.”
Quote in the paperNot a substantial claim - Interpretationown data
The CA3 region in Patients P13 and P14 is more pathologically affected than that of Patient P9.
“Importantly, the density of CA3 neurons in Patient P9 was 14 350 neurons/mm3, whereas there were only 8916 neurons/mm3 and 8447 neurons/mm3 in Patients P13 and P14, respectively (Supplementary material), suggesting that the CA3 region in the latter two patients is more pathologically affected than that of Patient P9.”
Quote in the paperSubstantial claim - Interpretationreasoning
There are some dendritic branches within a given neuron that are more affected than others, suggesting that cellulipetal disconnection does not occur synchronously across the whole dendritic arbor.
“Finally, there are some dendritic branches within a given neuron that are more affected than others, suggesting that this cellulipetal disconnection does not occur synchronously across the whole dendritic arbor.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The characteristic cognitive impairment in Alzheimer's disease is likely to depend on the relative number of neurons that are in intermediate and advanced stages of a neurofibrillar pathology, among other factors.
“In conclusion, neurons in the human brain that are recognized by PHF-tauAT8 and PHF-tauPHF-1 have not necessarily suffered severe and irreversible effects but rather, the characteristic cognitive impairment in Alzheimer’s disease is likely to depend on the relative number of neurons that are in intermediate and advanced stages of a neurofibrillar pathology, among other factors.”
Quote in the paperSubstantial claim - Interpretationown data
The presence of PHF-tauAT8 or PHF-tauPHF-1 is not necessarily associated with a loss of dendritic spines, even in intermediate stages of a neurofibrillar pathology.
“However, it should be emphasized that the presence of PHF-tauAT8 or PHF-tauPHF-1 is not necessarily associated with a loss of dendritic spines, even in intermediate stages of a neurofibrillar pathology.”
Quote in the paperSubstantial claim - Premisecitation
There are studies suggesting a strong correlation between the loss of synaptic markers and the presence of neurofibrillary tangles.
“Indeed, there are studies suggesting a strong correlation between the loss of synaptic markers and the presence of neurofibrillary tangles (Terry et al., 1991; Honer et al., 1992; Masliah et al., 1992; Wakabayashi et al., 1994; Lue et al., 1996; Samuel et al., 1997; Heffernan et al., 1998).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationown data
The characteristic cognitive impairment in Alzheimer's disease is likely to depend on the relative number of neurons that have well developed tangles.
“but rather, the characteristic cognitive impairment in Alzheimer’s disease is likely to depend on the relative number of neurons that have well developed tangles.”
Quote in the paperSubstantial claim- Rests on an assumption: Loss of synapses leads to cognitive decline in Alzheimer’s disease.
- Premisecitation
Dendritic spines on pyramidal cells are the recipients of most excitatory inputs to the cerebral cortex.
“Dendritic spines on pyramidal cells are the recipients of most excitatory inputs to the cerebral cortex (DeFelipe and Fariñas, 1992) and thus, the loss of dendritic spines indicates a synaptic disconnection that must certainly have an important consequence in the cognitive attributes of the patients with Alzheimer’s disease.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites DeFelipe and Fariñas, 1992 source
- Interpretationown data
The fact that neurons with well-developed tangles do not have dendritic spines or have very few compared with other neurons with less developed tangles in the same regions and in the same patients is interpreted as a decrease or loss of dendritic spines.
“The fact that neurons with well-developed tangles do not have dendritic spines or have very few compared with other neurons with less developed tangles in the same regions and in the same patients is therefore interpreted as a decrease or loss of dendritic spines.”
Quote in the paperSubstantial claim - Interpretationreasoning
The changes observed in the volume and length of dendritic spines in the present study are likely to have important functional consequences.
“Hence, the changes observed in the volume and length of dendritic spines in the present study are likely to have important functional consequences.”
Quote in the paperNot a substantial claim - Interpretationown data
The presence of phospho-tau in neurons does not necessarily mean that they suffer severe and irreversible effects as thought previously.
“Thus, the presence of phospho-tau in neurons does not necessarily mean that they suffer severe and irreversible effects as thought previously”
Quote in the paperSubstantial claim - Interpretationreasoning
The distal segments of these neurons are disconnected, unlike the rest of the dendritic tree.
“Assuming that the majority of the dendritic spines establish synapses (Arellano et al., 2007b), our results suggest that the distal segments of these neurons are disconnected, unlike the rest of the dendritic tree.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Arellano et al., 2007b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- The authors state this as an assumption: The majority of dendritic spines establish synapses.
- Interpretationreasoning
The decrease in dendritic spine density on CA1 neurons in Patients P13 and P14 could be due to a loss of excitatory inputs from Schaffer collaterals rather than to the presence of neurofibrillary tangles.
“Since CA3 pyramidal cells project strongly to the dendritic spines of CA1 pyramidal neurons (the Schaffer collateral projection; Andersen et al., 2007), it is possible that the decrease in dendritic spine density on CA1 neurons in Patients P13 and P14 could be due to a loss of excitatory inputs from Schaffer collaterals rather to the presence of neurofibrillary tangles.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Andersen et al., 2007
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
In neurons showing an intermediate state of neurofibrillar pathology (Pattern IIa), there is not necessarily a loss of dendritic spines.
“Nevertheless, we observed that in neurons showing an intermediate state of neurofibrillar pathology (Pattern IIa) there is not necessarily a loss of dendritic spines, since substantial reductions in the density of dendritic spines on CA1 pyramidal neurons with Pattern IIa was observed in Patients P13 and P14 but not in Patient P9.”
Quote in the paperSubstantial claim - Interpretationcitation
Differences in the number of dendritic spines probably reflect differences in the number of excitatory inputs that a cell can integrate.
“Assuming the hypothesis that one spine corresponds to one excitatory synapses (Arellano et al., 2007b), differences in the number of dendritic spines probably reflect differences in the number of excitatory inputs that a cell can integrate.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Arellano et al., 2007b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- The authors state this as an assumption: One spine corresponds to one excitatory synapse.
- Study design and conductown data
The study cannot determine whether the microanatomical changes found in Lucifer yellow-injected neurons with neurofibrillar pathology are characteristic of a particular subpopulation of neurons or also occur in neurons with other phosphorylated tau epitopes, because all such neurons examined were immunostained for PHF-tauAT8 or PHF-tauPHF-1.
“Because all Lucifer yellow-injected neurons with neurofibrillar pathology examined here were immunostained for PHF-tauAT8 or PHF-tauPHF-1, we do not know whether the changes found in the microanatomy of these neurons are characteristic of a particular subpopulation of neurons or similar changes occur in neurons with other phosphorylated tau epitopes.”
Quote in the paperSubstantial claim - Interpretationcitation
The change in dendrite diameter is likely to affect the physiological activity of the neuron.
“In any case, the change in dendrite diameter is likely to affect the physiological activity of the neuron as dendrite diameter is closely related to electrical conductivity (Holmes, 1989; Mainen and Sejnowski, 1996; Vetter et al., 2001).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationown data
There seems to be a sequence related to the loss of dendritic spines in association with intracellular tau pathology, occurring first in the distal and then in the more proximal regions.
“However, there seems to be a sequence related to the loss of dendritic spines in association with the intracellular tau pathology, occurring first in the distal and then in the more proximal regions (Fig. 9).”
Quote in the paperSubstantial claim - Interpretationreasoning
The loss of dendritic spines indicates a synaptic disconnection that must certainly have an important consequence in the cognitive attributes of patients with Alzheimer's disease.
“Dendritic spines on pyramidal cells are the recipients of most excitatory inputs to the cerebral cortex (DeFelipe and Fariñas, 1992) and thus, the loss of dendritic spines indicates a synaptic disconnection that must certainly have an important consequence in the cognitive attributes of the patients with Alzheimer’s disease.”
Quote in the paperNot a substantial claim
- Classified as probably not a substantial claim. 22
- May combine two claims. 30
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe size of the postsynaptic density is correlated with the number of presynaptic vesicles, the number of postsynaptic receptors and the ready-releasable pool of transmitter.
“In turn, the size of the postsynaptic density is correlated with the number of presynaptic vesicles, the number of postsynaptic receptors and the ready-releasable pool of transmitter (Harris and Stevens, 1989; Nusser et al., 1998; Schikorski and Stevens, 1999, 2001; Arellano et al., 2007a).”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites Harris and Stevens, 1989 source
The Serial electron microscopy section reports that PSD area is proportional to the number of vesicles in the presynaptic axonal varicosity. The Relationships between hippocampal spine geometry and synaptic efficacy section infers that larger PSDs likely contain more receptors, but does not count them. Neither section establishes a correlation with the readily releasable transmitter pool. Page numbers are not available in the indexed passages. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites Nusser et al., 1998 source
The Figure 4 description reports a positive correlation between synapse size and AMPA-receptor immunolabeling in hippocampal synapses. The paper does not establish that postsynaptic density size correlates with presynaptic vesicle number or the readily releasable transmitter pool; its introductory mention of pool size concerns variability, not that correlation. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites Schikorski and Stevens, 1999, 2001
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPrevious studies in animal models of Alzheimer's disease have shown that amyloid-β plaques induce local morphological alterations to the dendrites in contact with amyloid-β.
“Previous studies in animal models of Alzheimer’s disease have shown that amyloid-β plaques induce local morphological alterations to the dendrites in contact with amyloid-β (Tsai et al., 2004; Spires et al., 2005; Knafo et al., 2009a, b; Merino-Serrais et al., 2011).”
Quote in the paperNot a substantial claim1 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAbnormal phosphorylation of tau leads to the formation of paired helical filaments (PHFs), the main components of intraneuronal neurofibrillary tangles.
“In the brain, abnormal phosphorylation of the microtubule-associated protein tau leads to the formation of paired helical filaments (PHFs), the main components of intraneuronal neurofibrillary tangles (Grundke-Iqbal et al., 1986).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Grundke-Iqbal et al., 1986 source
The Abstract says the findings suggest that abnormally phosphorylated tau is a component of paired helical filaments (PHFs), and identifies neurofibrillary tangles as a major location of PHFs. It does not establish the stronger causal claim that abnormal phosphorylation leads to PHF formation. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe length of the spine neck is proportional to the extent of biochemical and electrical isolation of the spine from its parent dendrite.
“Moreover, the length of the spine neck is proportional to the extent of biochemical and electrical isolation of the spine from its parent dendrite (Majewska et al., 2000a, b; Araya et al., 2006).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites Majewska et al., 2000a, b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Araya et al., 2006 source
The opening section (page unavailable) says biochemical compartmentalization occurs at spine heads because the neck creates a diffusional bottleneck. It also reports that electrical attenuation increases with neck length. It does not establish that the extent of biochemical isolation is proportional to neck length. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSpine head volume is correlated with the area of the postsynaptic density.
“whereas the spine head volume is correlated with the area of the postsynaptic density.”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites Harris and Stevens, 1989 source
- cites Nusser et al., 1998 source
The Figure 2 caption describes a large synapse on a spine and other synapses on smaller spines, but does not establish a correlation between spine-head volume and postsynaptic-density area. Searches for that correlation and for spine volume versus synaptic area found no passage in our copy that states it; page numbers were unavailable. (LLM, conf=0.70)
Experimental — accuracy not yet measured - cites Schikorski and Stevens, 1999, 2001
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationPyramidal cells in different cortical regions have considerably distinct structures and the data obtained in one region cannot necessarily be applied to another.
“Second, pyramidal cells in different cortical regions have considerably distinct structures (Elston et al., 2001; Jacobs et al., 2001) and the data obtained in one region cannot necessarily be applied to another.”
Quote in the paperNot a substantial claim1 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe course such diseases take is highly variable as the neuropathological changes are not homogenous, neither among patients nor in different regions of the brain of the same patient, giving rise to variation in the alterations to cortical circuits.
“In addition, the course such diseases take is highly variable as the neuropathological changes are not homogenous, neither among patients nor in different regions of the brain of the same patient, giving rise to variation in the alterations to cortical circuits (Garcia-Marin et al., 2009; Blazquez-Llorca et al., 2010).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites Garcia-Marin et al., 2009 source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites Blazquez-Llorca et al., 2010
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationStudies on the European ground squirrel demonstrated that PHF-like phosphorylation is induced in the brain during hibernation.
“Studies on the European ground squirrel demonstrated that PHF-like phosphorylation is induced in the brain during the hibernation of these animals (Arendt et al., 2003), which is similar to the characteristic increase in tau phosphorylation (Avila et al., 2004).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Arendt et al., 2003 source
May combine two claims.
PremisecitationThe volume of the dendritic spine head is related to the size of the postsynaptic density, the number of presynaptic vesicles, and the number of vesicles adjacent to the presynaptic cleft.
“Additionally, the volume of the dendritic spine head is related to the size of the postsynaptic density (Harris and Stevens, 1989; Schikorski and Stevens, 1997; Arellano et al., 2007b), the number of presynaptic vesicles, and the number of vesicles adjacent to the presynaptic cleft (Harris and Stevens, 1989).”
Quote in the paperSubstantial claim2 of 3 sources checked- cites Harris and Stevens, 1989 source
The Serial electron microscopy section reports that spine head volume correlates with postsynaptic density area and with the total number of vesicles in the presynaptic axonal varicosity. It says all vesicles in those varicosities were counted, but does not report a separate relationship for vesicles adjacent to the synaptic cleft. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites Schikorski and Stevens, 1997 source
The Analysis section says the authors measured spine-head volumes and PSD areas, but does not report a relationship between them. Figure 3 (Appendix; page unavailable) reports a correlation between active-zone size and PSD size instead. The presynaptic-vesicle clauses are cited to Harris and Stevens (1989), not to this paper. (LLM, conf=0.72)
Experimental — accuracy not yet measured - cites Arellano et al., 2007b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe proximal and distal segments of basal dendrites have different characteristics with respect to integration and synaptic plasticity.
“Moreover, the proximal and distal segments of basal dendrites have different characteristics with respect to integration and synaptic plasticity (Markram et al., 1997; Hausser and Mel, 2003; Gordon et al., 2006; Gelfo et al., 2009; Branco and Häusser, 2011).”
Quote in the paperNot a substantial claim1 of 3 sources checkedClassified as probably not a substantial claim. May combine two claims.
PremisecitationAt the cellular level, abnormal tau phosphorylation and the formation of tangles are major events in neuronal degeneration in Alzheimer's disease.
“At the cellular level, abnormal tau phosphorylation and the formation of tangles are major events in neuronal degeneration in Alzheimer’s disease (Grundke-Iqbal et al., 1986).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Grundke-Iqbal et al., 1986 source
The Abstract (p. 4913) identifies neurofibrillary tangles in Alzheimer disease brain and suggests that tau in paired-helical filaments is abnormally phosphorylated. It does not establish that tangle formation and tau phosphorylation are major events in neuronal degeneration. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationPHF-tauAT8 mostly labels the initial stages of a neurofibrillar pathology, while PHF-tauPHF-1 recognizes the later stages.
“Indeed, the vast majority of PHF-tauPHF-1-ir neurons had a large amount of aggregated tau, consistent with the hypothesis that PHF-tauAT8 mostly labels the initial stages of a neurofibrillar pathology, while PHF-tauPHF-1 recognizes the later stages (Blazquez-Llorca et al., 2011).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Blazquez-Llorca et al., 2011 source
May combine two claims.
PremisecitationNeurofibrillary tangles appear to be toxic since they are associated with impaired axonal transport, which provokes cell death.
“However, neurofibrillary tangles appear to be toxic since they are associated with impaired axonal transport, which provokes cell death (Stamer et al., 2002; Terwel et al., 2002; Cente et al., 2006; Smith et al., 2007).”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites Stamer et al., 2002 source
The Discussion (page not provided) links elevated tau to impaired intracellular transport and suggests that resulting traffic jams may speed degeneration. It does not show that neurofibrillary tangles cause the transport defect or that the defect provokes cell death; it notes transport defects even when tau aggregates are absent or minor. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Terwel et al., 2002 source
- cites Cente et al., 2006 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThis interpretation is supported by a large number of researchers who study dendritic spine alterations both in humans and animal models.
“This interpretation is also supported by a large number of researchers who study dendritic spine alterations both in humans and animal models (see Penzes et al., 2011; Spires-Jones and Knafo, 2012 for recent reviews).”
Quote in the paperNot a substantial claim2 of 2 sources checkedMay combine two claims.
Findingown dataIn the CA1 region, the total neuron density was 15,786 in Patient P9, 11,916 in Patient P13 and 12,193 in Patient P14 (neurons/mm3), and the percentage of phospho-tau neurons varied between these patients.
“In the CA1 region, the total neuron density was 15 786 in Patient P9, 11 916 in Patient P13 and 12 193 in Patient P14 (neurons/mm3), and the percentage of phospho-tau neurons varied between these patients (Fig. 2 and Supplementary material).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn the parahippocampal cortex from Patient P9, all the Lucifer yellow-injected neurons analysed that were PHF-tau+ were considered to be Pattern I, whereas in the CA1 from Patients P9, P13 and P14, all the Lucifer yellow-injected neurons analysed that were PHF-tau+ were Pattern IIa.
“In the parahippocampal cortex from Patient P9, all the Lucifer yellow-injected neurons analysed that were PHF-tau+ were considered to be Pattern I, whereas in the CA1 from Patients P9, P13 and P14, all the Lucifer yellow-injected neurons analysed that were PHF-tau+ were Pattern IIa.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThere were significant differences in the frequency distribution of the volume of dendritic spines for all cases, whereby small dendritic spines were more frequent in PHF-tau+ neurons than in PHF-tau− neurons.
“However, there were significant differences in the frequency distribution of the volume of dendritic spines for all cases, whereby small dendritic spines were more frequent in PHF-tau+ neurons than in PHF-tau− neurons (Fig. 8L, O and R).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn Patient P9, the total neuron density in the parahippocampal cortex was 19,560 neurons/mm3, whereas the density of PHF-tauAT8-ir and PHF-tauPHF-1-ir neurons was 2917 and 499 neurons/mm3, respectively (15% and 2.5% of the total neuronal density).
“In Patient P9, the total neuron density in the parahippocampal cortex was 19 560 neurons/mm3, whereas the density of PHF-tauAT8-ir and PHF-tauPHF-1-ir neurons was 2917 and 499 neurons/mm3, respectively (Fig. 2), 15% and 2.5% of the total neuronal density, respectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAll Lucifer yellow-injected neurons that were PHF-tauAT8-ir were also PHF-tauPHF-1, whereas some Lucifer yellow-injected neurons that were non-immunostained for PHF-tauAT8 were also labelled for PHF-tauPHF-1.
“All Lucifer yellow-injected neurons that were PHF-tauAT8-ir were also PHF-tauPHF-1, whereas some Lucifer yellow-injected neurons that were non-immunostained for PHF-tauAT8 were also labelled for PHF-tauPHF-1 (Supplementary Fig. 5).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataPattern II was subdivided into Patterns IIa (intermediate/advanced stages) and IIb (extreme stage) depending on the extent of neurofibrillary tangle development.
“In the present study, we further subdivided Pattern II into Patterns IIa and IIb, depending on the extent of neurofibrillary tangle development visualized with PHF-tauAT8, PHF-tauPHF-1 and thioflavin S (Pattern IIa, intermediate/advanced stages; Pattern IIb, extreme stage: Fig. 3).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe average dendritic spine length decreased significantly in Patient P9 (14%), whereas no differences were found in Patients P13 and P14.
“The average dendritic spine length decreased significantly in Patient P9 (14%, Fig. 8B), whereas no differences were found in Patients P13 and P14 (Fig. 8E and H; Supplementary Table 2).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe frequency distribution revealed a higher frequency of shorter dendritic spines in PHF-tau+ neurons from Patients P9 and P13, whereas in Patient P14 short dendritic spines were less frequent on PHF-tau+ neurons than PHF-tau− neurons.
“The frequency distribution revealed a higher frequency of shorter dendritic spines in PHF-tau+ neurons from Patients P9 and P13 (Fig. 8C and F), whereas in Patient P14 short dendritic spines were less frequent on PHF-tau+ neurons than PHF-tau− neurons (Fig. 8I).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn Patients P13 and P14, there were statistical differences between PHF-tau− and PHF-tau+ neurons in the medial/distal portions of dendritic spine density, and similar results were found when the data are presented as the average.
“By contrast, in Patients P13 and P14 we found statistical differences between PHF-tau− and PHF-tau+ neurons in the medial/distal portions (Fig. 7C and E), and similar results were found when the data are presented as the average (Fig. 7D and F; Supplementary Table 2).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPHF-tau+ neurons that had well developed neurofibrillary tangles (Pattern IIb) had a reduced dendritic arbor and few or virtually no dendritic spines; the dendritic diameter was also remarkably thin in all these cases.
“However, when PHF-tau+ neurons that had well developed neurofibrillary tangles (Pattern IIb) were injected, these neurons had a reduced dendritic arbor and few or virtually no dendritic spines. The dendritic diameter was also remarkably thin in all these cases (Fig. 6).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOur results indicate that neurons with advanced neurofibrillary tangles display a remarkable loss of dendritic spines, which is consistent with other studies.
“Our results indicate that neurons with advanced neurofibrillary tangles display a remarkable loss of dendritic spines, which is consistent with other studies.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe density of CA3 neurons in Patient P9 was 14,350 neurons/mm3, whereas there were only 8916 neurons/mm3 and 8447 neurons/mm3 in Patients P13 and P14, respectively.
“Importantly, the density of CA3 neurons in Patient P9 was 14 350 neurons/mm3, whereas there were only 8916 neurons/mm3 and 8447 neurons/mm3 in Patients P13 and P14, respectively (Supplementary material), suggesting that the CA3 region in the latter two patients is more pathologically affected than that of Patient P9.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNo changes were found in the number, length or volume of dendritic spines in neurons with Pattern I, nor in dendrite diameter.
“As summarized in Fig. 9, no changes were found in the number, length or volume of the dendritic spines in neurons with Pattern I, nor in dendrite diameter, whereas several significant alterations were found in neurons showing Pattern II.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDendritic spines on pyramidal cells are the main postsynaptic target of excitatory synapses in the cerebral cortex.
“The dendritic spines on pyramidal cells are the main postsynaptic target of excitatory synapses in the cerebral cortex and thus, pyramidal cells are considered the principal building blocks of this structure (DeFelipe and Fariñas, 1992).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites DeFelipe and Fariñas, 1992 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningBoth PHF-tauAT8 and PHF-tauPHF-1 antibodies were produced in mouse; thus the labeling of neurons for both PHF-tauAT8 and PHF-tauPHF-1 could be due to antibody cross-reactivity.
“Nevertheless, it is important to mention that both PHF-tauAT8 and PHF-tauPHF-1 antibodies were produced in mouse. Thus, the labeling of neurons for both PHF-tauAT8 PHF-tauPHF-1 could be due to antibody cross-reactivity.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIntracellular injections of marker substances in fixed brain tissue is currently considered the best approach to visualize the dendritic spines in the human brain and is a well-established technique.
“Another method involving intracellular injections of marker substances in fixed brain tissue is currently considered the best approach to visualize the dendritic spines in the human brain and is a well-established technique (Einstein, 1988; Buhl et al., 1990).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Einstein, 1988 source
- cites Buhl et al., 1990
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationreasoningThis result is suggestive of a local toxic effect, since the density of dendritic spines in the pre-terminal dendritic segment was similar to that found in dendrites lacking PHF-tauAT8.
“This result is suggestive of a local toxic effect, since the density of dendritic spines in the pre-terminal dendritic segment was similar to that found in dendrites lacking PHF-tauAT8.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductnone givenIt is not possible to know which neurons have developed a neurofibrillar pathology before injection and hence the proportion of cells showing a neurofibrillar pathology is rather unpredictable.
“In addition, it is not possible to know which neurons have developed a neurofibrillar pathology before injection and hence, the proportion of cells showing a neurofibrillar pathology is rather unpredictable.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
Study design and conductnone givenThe morphological alterations observed in human pathological tissue are very difficult to interpret due to the high interindividual variability (sex, age, medical treatment, etc.), factors that could affect brain structure.
“Third, the morphological alterations observed in human pathological tissue are very difficult to interpret due to the high interindividual variability (sex, age, medical treatment, etc.), factors that could affect brain structure.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPattern II neurons typically form neurofibrillary tangles (tangle stage).
“Neurons with Pattern II typically form neurofibrillary tangles (tangle stage).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Blazquez-Llorca et al., 2010
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe small dendritic tree, thin dendrites, and very few or no spines in Pattern IIb neurons may simply be due to a more advanced stage of atrophy.
“Finally, Lucifer yellow-injected neurons with Pattern IIb (with well-developed neurofibrillary tangles) had a relatively small dendritic tree, with thin dendrites and very few or no spines, which may simply be due to a more advanced stage of atrophy.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationChanges in the denervation/reinnervation of CA3 pyramidal neurons by mossy fibres were found during hibernation/arousal and were associated with a reversible PHF-like phosphorylation of tau over a similar time course.
“Furthermore, changes in the denervation/reinnervation of CA3 pyramidal neurons by mossy fibres were also found during hibernation/arousal (Popov and Bocharova, 1992) and they were associated with a reversible PHF-like phosphorylation of tau over a similar time course.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Popov and Bocharova, 1992 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSynaptic connections of axons that arise within the same cortical column in the neocortex preferentially innervate the proximal basal dendrites of pyramidal cells.
“For example, the synaptic connections of axons that arise within the same cortical column in the neocortex preferentially innervate the proximal basal dendrites of pyramidal cells (Markram et al., 1997; Feldmeyer et al., 2002).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Interpretationown dataNeurons in a putative pre-tangle stage or with neurofibrillary tangles in intermediate stages may not be affected (or they may be only slightly affected) or they may be in a reversible state.
“These observations suggest that neurons in a putative pre-tangle stage or with neurofibrillary tangles in intermediate stages may not be affected (or they may be only slightly affected) or they may be in a reversible state.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn animal models, changes in the neck length of dendritic spines affect the temporal compartmentalization of calcium and other second messengers, changes that may affect the induction of long-term potentiation.
“In animal models, changes in the neck length of dendritic spines affects the temporal compartmentalization of calcium and other second messengers, changes that may affect the induction of long-term potentiation (Yuste, 2010; Bloodgood and Sabatini, 2005).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningTau phosphorylation at the site recognized by the antibody AT8 may be a suitable marker for the initial steps of degeneration, as increased tau aggregation can subsequently be found in some neurons and it can be readily visualized with the PHF-1 tau antibody.
“This may be a suitable marker for the initial steps of degeneration, as increased tau aggregation can subsequently be found in some neurons and it can be readily visualized with the PHF-1 tau antibody (PHF-tauPHF-1).”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningCellulipetal disconnection may occur and the functional consequences of such a process are likely to be selective and progressive in the cerebral cortex as a whole, at least at the cellular level.
“These observations suggest that cellulipetal disconnection may occur and that the functional consequences of such a process are likely to be selective and progressive in the cerebral cortex as a whole, at least at the cellular level.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThe selective and progressive functional consequences of cellulipetal disconnection may also occur in other cortical regions.
“This is not only evident for the proximal, intermediate and distal dendrites of pyramidal neurons in the hippocampus, where neurons in all cornu ammonis fields establish different types of synaptic contacts in each strata that they traverse (Andersen et al., 2007), but it may also occur in other cortical regions.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Andersen et al., 2007
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationreasoningThe morphology of a dendritic spine determines its synaptic strength and learning rules.
“Therefore, the morphology of a dendritic spine determines its synaptic strength and learning rules.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNeurons in all cornu ammonis fields establish different types of synaptic contacts in each strata that they traverse.
“This is not only evident for the proximal, intermediate and distal dendrites of pyramidal neurons in the hippocampus, where neurons in all cornu ammonis fields establish different types of synaptic contacts in each strata that they traverse (Andersen et al., 2007), but it may also occur in other cortical regions.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Andersen et al., 2007
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationcitationThe sequential loss of dendritic spines in association with intracellular tau pathology appears distinct from that found in the presence of amyloid-β plaques, where dendritic regions close to extracellular plaques are depleted of dendritic spines irrespective of whether they are proximal or distal to the soma.
“This sequential loss of dendritic spines appears to be distinct to that found in the presence of amyloid-β plaques, where the dendritic regions close to the extracellular plaques are depleted of dendritic spines irrespective of whether they are proximal or distal to the soma (Knafo et al., 2009a).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Knafo et al., 2009a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
InterpretationreasoningSuch variation could reflect different steps in the process of neuronal degeneration.
“Such variation could reflect different steps in the process of neuronal degeneration.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Loss of synapses leads to cognitive decline in Alzheimer’s disease.
“the presence of PHF-tau is likely to be involved in the changes to dendritic spines and the loss of synapses that leads to cognitive decline in Alzheimer’s disease.”
The paper relies on this without support.
Lower density of neurons in CA3 indicates more advanced CA3 pathology.
“the density of neurons in the CA3 was lower in these latter patients than in Patient P9 (38% and 42% fewer neurons, respectively), suggesting that the CA3 pathology was more advanced in these patients than in Patient P9”
The authors state this as an assumption.
One spine corresponds to one excitatory synapse.
“Assuming the hypothesis that one spine corresponds to one excitatory synapses (Arellano et al., 2007b)”
The authors state this as an assumption.
The majority of dendritic spines establish synapses.
“Assuming that the majority of the dendritic spines establish synapses (Arellano et al., 2007b)”
The authors state this as an assumption.
Neuronal degeneration and atrophy is progressive.
“if we assume the widely accepted hypothesis that neuronal degeneration and atrophy is progressive”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Toxic species of aggregated tau affect pyramidal-cell dendritic complexity even before axonal aggregation.
“Toxic species of aggregated tau affect pyramidal‐cell dendritic complexity 10 , 16 even before axonal aggregation. 10”
From Alzheimer's disease and its progression reduce pyramidal cell gain and connectivity (2025) · cites this paper as [16]
The Discussion reports that pyramidal neurons with tau aggregates forming neurofibrillary tangles had reduced dendrite diameter and altered spines, while neurons with diffuse phospho-tau in a putative pre-tangle state showed no significant dendritic changes. It does not establish that these changes occur before axonal aggregation, and its findings are associations rather than proof that aggregated tau causes them. (LLM, conf=0.86)
Experimental — accuracy not yet measuredThe effect of aggregated tau on cognition in part results from synaptic toxicity and dendritic de-arborization of pyramidal cells.
“The effect of aggregated tau on cognition in part results from synaptic toxicity and dendritic de‐arborization of pyramidal cells. 16 , 17”
From Alzheimer's disease and its progression reduce pyramidal cell gain and connectivity (2025) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
P9 CA1 neuron counts exceed the number injected
MajorOf the 40 CA1 neurons injected in Patient P9, 34 are reported as PHF-tau−. The paper then reports analysing dendrites from nine different PHF-tau+ neurons in that group, requiring at least 43 injected neurons.
Reported 40 · recomputed 43
“We analysed six, five and five dendrites from different PHF-tau− neurons and nine, eight and six dendrites from different PHF-tau+ neurons in Patients P9, P13 and P14, respectively”
CA1 patient identified as P4 instead of P14
MinorThe CA1 injected-neuron counts are assigned to P9, P13 and P4, but the immediately following analysis assigns the corresponding patient groups to P9, P13 and P14.
“Of the 40, 62 and 48 neurons in the CA1 of Patients P9, P13 and P4 injected with Lucifer yellow”
“We analysed six, five and five dendrites from different PHF-tau− neurons and nine, eight and six dendrites from different PHF-tau+ neurons in Patients P9, P13 and P14, respectively”
Claim of shorter spines in all patients conflicts with P14 results
MinorThe summary says spine length was shorter in all patients with Pattern IIa neurons, but the P14 results report no difference in average length and a lower frequency of short spines on PHF-tau+ neurons.
“changes in the morphology of dendritic spines (smaller volume and shorter length) in all patients”
“whereas in Patient P14 short dendritic spines were less frequent on PHF-tau+ neurons than PHF-tau− neurons”
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · see citing works
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · see citing works
Handbook of Chemical Neuroanatomy
Stern, C. D. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90021-5 · Cited by 4,159 · see citing works
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676 · see citing works
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859 · see citing works
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014 · see citing works
Pyramidal neurons: dendritic structure and synaptic integration
Spruston, N. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2286 · Cited by 1,688 · see citing works
Dendritic spine pathology in neuropsychiatric disorders
Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523 · see citing works
Influence of dendritic structure on firing pattern in model neocortical neurons
Mainen, Z. F., & Sejnowski, T. J. (1996) · Nature · doi:10.1038/382363a0 · Cited by 1,231 · see citing works
(2006) · doi:10.1093/acprof:oso/9780195100273.001.0001 · Cited by 1,186 · see citing works
Heterogeneity of release probability, facilitation, and depletion at central synapses
Dobrunz, L. E., & Stevens, C. F. (1997) · Neuron · doi:10.1016/s0896-6273(00)80338-4 · Cited by 1,183 · see citing works
Harris, K., & Stevens, J. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-08-02982.1989 · Cited by 1,073 · see citing works
Tau pathology in Alzheimer disease and other tauopathies
Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.008 · Cited by 1,037 · see citing works
Role of tau protein in both physiological and pathological conditions
AVILA, J., LUCAS, J. J., PÉREZ, M., & HERNÁNDEZ, F. (2004) · Physiological Reviews · doi:10.1152/physrev.00024.2003 · Cited by 1,005 · see citing works
Quantitative ultrastructural analysis of hippocampal excitatory synapses
Schikorski, T., & Stevens, C. F. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05858.1997 · Cited by 997 · see citing works
DeFelipe, J., & Fariñas, I. (1992) · Progress in Neurobiology · doi:10.1016/0301-0082(92)90015-7 · Cited by 975 · see citing works
Self-citationAlonso, A. D. C., Zaidi, T., Novák, M., Grundke, I., & Iqbal, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121119298 · Cited by 968 · see citing works
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Hanger, D. P., Anderton, B. H., & Noble, W. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.003 · Cited by 965 · see citing works
Markram, H., Lübke, J., Frotscher, M., Roth, A., & Sakmann, B. (1997) · The Journal of Physiology · doi:10.1113/jphysiol.1997.sp022031 · Cited by 960 · see citing works
Stamer, K., Vogel, R., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108057 · Cited by 885 · see citing works
Bancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seitelberger, F., Grundke-Iqbal, I., Iqbal, K., & Wisniewski, H. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)91396-6 · Cited by 818 · see citing works
Dendritic Spine Pathology: Cause or Consequence of Neurological Disorders?
Fiala, J. C., Spacek, J., & Harris, K. M. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00158-3 · Cited by 811 · see citing works
Cell Type and Pathway Dependence of Synaptic AMPA Receptor Number and Variability in the Hippocampus
Nusser, Z., Lujan, R., Laube, G., Roberts, J. D. B., Molnar, E., & Somogyi, P. (1998) · Neuron · doi:10.1016/s0896-6273(00)80565-6 · Cited by 804 · see citing works
Braak, F., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 773 · see citing works
Neurons born in the adult dentate gyrus form functional synapses with target cells
Toni, N., Laplagne, D. A., Zhao, C., Lombardi, G., Ribak, C. E., Gage, F. H., & Schinder, A. F. (2008) · Nature Neuroscience · doi:10.1038/nn.2156 · Cited by 741 · see citing works
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms
Andorfer, C., Kress, Y., Espinoza, M., De Silva, R., Tucker, K. L., Barde, Y., Duff, K., & Davies, P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01879.x · Cited by 722 · see citing works
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease
Price, J. L., McKeel, D. W., Buckles, V. D., Roe, C. M., Xiong, C., Grundman, M., Hansen, L. A., Petersen, R. C., Parisi, J. E., Dickson, D. W., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.002 · Cited by 661 · see citing works
Feldmeyer, D., Lübke, J., Silver, R. A., & Sakmann, B. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.012959 · Cited by 656 · see citing works
Mechanisms of tau-induced neurodegeneration
Iqbal, K., Liu, F., Gong, C.-X., Alonso, A. D. C., & Grundke-Iqbal, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0486-3 · Cited by 628 · see citing works
Propagation of action potentials in dendrites depends on dendritic morphology
Vetter, P., Roth, A., & Häusser, M. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.2.926 · Cited by 598 · see citing works
Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches
Tsai, J., Grutzendler, J., Duff, K., & Gan, W.-B. (2004) · Nature Neuroscience · doi:10.1038/nn1335 · Cited by 561 · see citing works
Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration
Wang, J., Grundke, I., & Iqbal, K. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05226.x · Cited by 553 · see citing works
Spires, T. L., Meyer-Luehmann, M., Stern, E. A., McLean, P. J., Skoch, J., Nguyen, P. T., Bacskai, B. J., & Hyman, B. T. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1879-05.2005 · Cited by 550 · cited 3× · see citing works
“Previous studies in animal models of Alzheimer’s disease have shown that amyloid-b plaques induce local morphological alterations to the dendrites in contact with amyloid-b (Tsai et al., 2004; Spires et al., 2005; Knafo et al., 2009a, b; Merino-Serrais et al., 2011).”
BackgroundResultUltrastructure of dendritic spines: correlation between synaptic and spine morphologies
Arellano, J. I. (2007) · Frontiers in Neuroscience · doi:10.3389/neuro.01.1.1.010.2007 · Cited by 529 · see citing works
Morphological correlates of functionally defined synaptic vesicle populations
Schikorski, T., & Stevens, C. F. (2001) · Nature Neuroscience · doi:10.1038/86042 · Cited by 516 · see citing works
Regional Dendritic and Spine Variation in Human Cerebral Cortex: a Quantitative Golgi Study
Jacobs, B. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.6.558 · Cited by 423 · see citing works
Microtubule-associated protein tau in development, degeneration and protection of neurons
Wang, J., & Liu, F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.002 · Cited by 395 · see citing works
Häusser, M., & Mel, B. (2003) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(03)00075-8 · Cited by 392 · see citing works
From form to function: calcium compartmentalization in dendritic spines
Yuste, R., Majewska, A. K., & Holthoff, K. (2000) · Nature Neuroscience · doi:10.1038/76609 · Cited by 370 · see citing works
Arendt, T., Stieler, J., Strijkstra, A. M., Hut, R. A., Rüdiger, J., Van der Zee, E. A., Harkany, T., Holzer, M., & Härtig, W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-06972.2003 · Cited by 357 · see citing works
Synaptic Integration Gradients in Single Cortical Pyramidal Cell Dendrites
Branco, T., & Häusser, M. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.006 · Cited by 351 · see citing works
Neuronal activity regulates diffusion across the neck of dendritic spines
Bloodgood, B. L., & Sabatini, B. L. (2005) · Science · doi:10.1126/science.1114816 · Cited by 344 · see citing works
The pyramidal cell in cognition: a comparative study in human and monkey
Elston, G. N., Benavides-Piccione, R., & DeFelipe, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-j0002.2001 · Cited by 317 · see citing works
Self-citationLue, L. F., Brachova, L., CIVIN, W. H., & Rogers, J. (1996) · PubMed · Cited by 299 · see citing works
Mocanu, M.-M., Nissen, A., Eckermann, K., Khlistunova, I., Biernat, J., Drexler, D., Petrova, O., Schönig, K., Bujard, H., Mandelkow, E., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2824-07.2008 · Cited by 297 · see citing works
The spine neck filters membrane potentials
Araya, R., Jiang, J., Eisenthal, K. B., & Yuste, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608755103 · Cited by 258 · see citing works
Regulation by gastric acid of the processing of progastrin‐derived peptides in rat antral mucosa
Macro, J. A., Bate, G. W., Varró, A., Vaillant, C., Seidah, N. G., Dimaline, R., & Dockray, G. J. (1997) · The Journal of Physiology · doi:10.1111/j.1469-7793.1997.409bk.x · Cited by 257 · see citing works
Majewska, A., Brown, E., Ross, J., & Yuste, R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-05-01722.2000 · Cited by 248 · see citing works
Lue, L.-F., Brachova, L., Civin, H. W., & Rogers, J. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199655100-00008 · Cited by 246 · cited 1× · see citing works
“Indeed, there are studies suggesting a strong correlation between the loss of synaptic markers and the presence of neurofibrillary tangles (Terry et al., 1991; Honer et al., 1992; Masliah et al., 1992; Wakabayashi et al., 1994; Lue et al., 1996; Samuel et al., 1997; Heffernan et al., 1998).”
BackgroundYuste, R. (2010) · doi:10.7551/mitpress/9780262013505.001.0001 · Cited by 241 · see citing works
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
Lee, H., Perry, G. L., Moreira, P. I., Garrett, M. R., Liu, Q., Zhu, X., Takeda, A., Nunomura, A., & Smith, M. A. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.02.008 · Cited by 240 · see citing works
Phosphorylation of tau at Thr212, Thr231, and Ser262 combined causes neurodegeneration
Alonso, A. D., Di Clerico, J., Li, B., Corbo, C. P., Alaniz, M. E., Grundke-Iqbal, I., & Iqbal, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.110957 · Cited by 236 · see citing works
Failure of Neuronal Maturation in Alzheimer Disease Dentate Gyrus
Li, B., Yamamori, H., Tatebayashi, Y., Shafit-Zagardo, B., Tanimukai, H., Chen, S., Iqbal, K., & Grundke-Iqbal, I. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318160c5db · Cited by 234 · see citing works
Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity
Alonso, A. D. C., Li, B., Grundke-Iqbal, I., & Iqbal, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603214103 · Cited by 206 · see citing works
Quantitative fine-structural analysis of olfactory cortical synapses
Schikorski, T., & Stevens, C. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.4107 · Cited by 204 · see citing works
Popov, V. I., & Bocharova, L. S. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90337-2 · Cited by 203 · see citing works
Regulation of Spine Calcium Dynamics by Rapid Spine Motility
Majewska, A. K., Tashiro, A., & Yuste, R. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08262.2000 · Cited by 201 · see citing works
Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs
Rocher, A. B., Crimins, J. L., Amatrudo, J. M., Kinson, M. S., Todd-Brown, M. A., Lewis, J., & Luebke, J. I. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.029 · Cited by 187 · see citing works
Masliah, E., Ellisman, M., Carragher, B., Mallory, M., Young, S., Hansen, L., Deteresa, R., & Terry, R. D. (1992) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199207000-00003 · Cited by 183 · see citing works
Regional synaptic pathology in Alzheimer's disease
Honer, W. G., Dickson, D. W., Gleeson, J., & Davies, P. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90111-a · Cited by 179 · see citing works
Benavides‐Piccione, R., Fernaud-Espinosa, I., Robles, V., Yuste, R., & DeFelipe, J. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs154 · Cited by 173 · see citing works
Self-citationNon-synaptic dendritic spines in neocortex
Arellano, J. I., Espinosa, A., Fairén, A. G., Yuste, R., & DeFelipe, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.015 · Cited by 171 · see citing works
Self-citationDementia with Lewy Bodies Versus Pure Alzheimer Disease
Samuel, W., Alford, M. F., Hofstetter, C. R., & Hansen, L. A. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199705000-00006 · Cited by 167 · see citing works
Plasticity compartments in basal dendrites of neocortical pyramidal neurons
Gordon, U., Polsky, A., & Schiller, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3502-06.2006 · Cited by 157 · see citing works
In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease
Smith, K. D. B., Kallhoff, V., Zheng, H., & Pautler, R. G. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.01.046 · Cited by 150 · see citing works
Multiple events lead to dendritic spine loss in triple transgenic Alzheimer’s disease mice
Bittner, T., Fuhrmann, M., Burgold, S., Ochs, S. M., Hoffmann, N., Mitteregger, G., Kretzschmar, H., LaFerla, F. M., & Herms, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015477 · Cited by 149 · see citing works
Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease
Terwel, D., Dewachter, I., & Van Leuven, F. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:2:2:151 · Cited by 146 · see citing works
Spires-Jones, T. L., de Calignon, A., Matsui, T., Zehr, C., Pitstick, R., Wu, H.-Y., Osetek, J. D., Jones, P. B., Bacskai, B. J., Feany, M. B., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3072-08.2008 · Cited by 137 · see citing works
Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques
Garcia-Marin, V. (2009) · Frontiers in Neuroanatomy · doi:10.3389/neuro.05.028.2009 · Cited by 136 · see citing works
Erratum to “Development of Brainstem-Evoked Responses in Congenital Auditory Deprivation”
Tillein, J., Heid, S., Lang, E., Hartmann, R., & Kral, A. (2012) · Neural Plasticity · doi:10.1155/2012/168297 · Cited by 135 · see citing works
Spines, plasticity, and cognition in Alzheimer's model mice
Spires-Jones, T., & Knafo, S. (2012) · Neural Plasticity · doi:10.1155/2012/319836 · Cited by 133 · see citing works
Widespread Changes in Dendritic Spines in a Model of Alzheimer's Disease
Knafo, S., Alonso-Nanclares, L., Gonzalez-Soriano, J., Merino-Serrais, P., Fernaud-Espinosa, I., Ferrer, I., & DeFelipe, J. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn111 · Cited by 132 · see citing works
Self-citationOn dendrites in Down syndrome and DS murine models: a spiny way to learn
Benavides‐Piccione, R. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.08.001 · Cited by 124 · see citing works
Self-citationTau Phosphorylation by GSK3 in Different Conditions
Ávila, J., León‐Espinosa, G., García, E., García‐Escudero, V., Hernández, F., & DeFelipe, J. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/578373 · Cited by 119 · see citing works
Self-citationLuebke, J. I., Weaver, C. M., Rocher, A. B., Rodriguez, A., Crimins, J. L., Dickstein, D. L., Wearne, S. L., & Hof, P. R. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0244-2 · Cited by 113 · see citing works
Wakabayashi, K., Honer, W., & Masliah, E. (1994) · Brain Research · doi:10.1016/0006-8993(94)91709-4 · Cited by 98 · see citing works
Phosphorylated Tau: Toxic, Protective, or None of the Above
Castellani, R. J., Nunomura, A., Lee, H., Perry, G. L., & Smith, M. A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14404 · Cited by 92 · see citing works
Layer and regional effects of environmental enrichment on the pyramidal neuron morphology of the rat
Gelfo, F., Bartolo, P. D., Giovine, A., Petrosini, L., & Leggio, M. G. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.01.010 · Cited by 85 · see citing works
Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy
Cente, M., Filipcik, P., Pevalova, M., & Novak, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04986.x · Cited by 82 · see citing works
The role of dendritic diameters in maximizing the effectiveness of synaptic inputs
Holmes, W. R. (1989) · Brain Research · doi:10.1016/0006-8993(89)91484-4 · Cited by 75 · see citing works
Knafo, S., Venero, C., Merino‐Serrais, P., Fernaud-Espinosa, I., González‐Soriano, J., Ferrer, I., Santpere, G., & DeFelipe, J. (2009) · The Journal of Pathology · doi:10.1002/path.2565 · Cited by 73 · see citing works
Self-citationEinstein, G. (1988) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(88)90157-4 · Cited by 58 · see citing works
Curcumin Labeling of Neuronal Fibrillar Tau Inclusions in Human Brain Samples
Mohorko, N., Repovš, G., Popović, M., Kovács, G. G., & Bresjanac, M. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d709eb · Cited by 58 · see citing works
Heffernan, J. M., Eastwood, S. L., Nagy, Z., Sanders, M. W., McDonald, B., & Harrison, P. J. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6772 · Cited by 57 · see citing works
Pathological plasticity in fragile X syndrome.
Martin, B. S., & Huntsman, M. M. (2012) · Neural Plasticity · doi:10.1155/2012/275630 · Cited by 57 · see citing works
Characteristics of the binding of thioflavin S to tau paired helical filaments
Santa‐María, I., Pérez, M., Hernández, F., Ávila, J., & Moreno, F. J. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9307 · Cited by 53 · see citing works
Layer‐specific alterations to CA1 dendritic spines in a mouse model of Alzheimer's disease
Merino‐Serrais, P., Knafo, S., Alonso‐Nanclares, L., Fernaud-Espinosa, I., & DeFelipe, J. (2010) · Hippocampus · doi:10.1002/hipo.20861 · Cited by 49 · see citing works
Self-citationBlazquez-Llorca, L., Garcia-Marin, V., Merino-Serrais, P., Ávila, J., & DeFelipe, J. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2011-110659 · Cited by 44 · see citing works
Self-citationBlázquez‐Llorca, L. (2010) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2010.00020 · Cited by 25 · see citing works
Flagged first, then by citations
1 of the 91 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Buhl, 1990, Intracellular injection of neurons in fixed brain tissue combined with other neuroanatomical techniques at the light- and electron- microscopic level, 273
Cited by
Sorted by citations
Arendt, T., Stieler, J. T., & Holzer, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.018 · Cited by 609 · see citing works
Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction
Mietelska‐Porowska, A., Wasik, U., Goras, M., Filipek, A., & Niewiadomska, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034671 · Cited by 407 · see citing works
Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies
Polanco, J. C., Li, C., Bodea, L., Martínez‐Mármol, R., Meunier, F. A., & Götz, J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.162 · Cited by 374 · see citing works
Alquezar, C., Arya, S., & Kao, A. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.595532 · Cited by 367 · see citing works
Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease
Arnsten, A. F. T., Datta, D., Del Tredici, K., & Braak, H. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12192 · Cited by 361 · see citing works
Matarin, M., Salih, D. A., Yasvoina, M., Cummings, D. M., Guelfi, S., Liu, W., Nahaboo Solim, M. A., Moens, T. G., Paublete, R. M., Ali, S. S., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.041 · Cited by 290 · see citing works
Frandemiche, M. L., De Seranno, S., Rush, T., Borel, E., Elie, A., Arnal, I., Lanté, F., & Buisson, A. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4261-13.2014 · Cited by 272 · see citing works
Protein phosphorylation in neurodegeneration: friend or foe?
Tenreiro, S., Eckermann, K., & Outeiro, T. F. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00042 · Cited by 252 · see citing works
Maestú, F., de Haan, W., Busche, M. A., & DeFelipe, J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101372 · Cited by 235 · see citing works
Self-citationAnalyzing dendritic spine pathology in Alzheimer’s disease: Problems and opportunities
Dorostkar, M. M., Zou, C., Blazquez-Llorca, L., & Herms, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1449-5 · Cited by 235 · see citing works
Loera‐Valencia, R., Goikolea, J., Parrado‐Fernández, C., Merino‐Serrais, P., & Maioli, S. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.03.003 · Cited by 228 · see citing works
Self-citationAtypical, non-standard functions of the microtubule associated Tau protein
Sotiropoulos, I., Galas, M., Silva, J. M., Skoulakis, E. M. C., Wegmann, S., Maina, M. B., Blum, D. L., Sayas, C. L., Mandelkow, E., Mandelkow�, E., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0489-6 · Cited by 211 · see citing works
Colom‐Cadena, M., Davies, C., Sirisi, S., Lee, J., Simzer, E. M., Tzioras, M., Querol‐Vilaseca, M., Sánchez‐Aced, É., Chang, Y. Y., Holt, K., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.04.020 · Cited by 203 · see citing works
Synapse pathology in Alzheimer’s disease
Griffiths, J., & Grant, S. G. N. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.05.028 · Cited by 203 · see citing works
Animal models of Alzheimer’s disease: Applications, evaluation, and perspectives
Chen, Z.-Y., 北京大学生命科学学院膜生物学国家重点实验室, 北. 1., State Key Laboratory of Membrane Biology, C. O. L. S., & Zhang, Y. (2022) · Zoological Research · doi:10.24272/j.issn.2095-8137.2022.289 · Cited by 155 · see citing works
Braak, H., & Del Tredici, K. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy152 · Cited by 148 · see citing works
Tau protein is essential for stress-induced brain pathology
Lopes, S., Vaz‐Silva, J., Pinto, V., Dalla, C., Kokras, N., Bedenk, B. T., Mack, N., Czisch, M., Almeida, O. F. X., Sousa, N., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600953113 · Cited by 147 · see citing works
Chen, Y., Chen, Y., Liang, Y., Chen, H.-D., Ji, X., & Huang, M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109670 · Cited by 145 · see citing works
Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects
Pereira, J. B., Janelidze, S., Stomrud, E., Palmqvist, S., van Westen, D., Dage, J. L., Mattsson, N., & Hansson, O. (2021) · Brain · doi:10.1093/brain/awab163 · Cited by 142 · see citing works
Burlot, M., Braudeau, J., Michaelsen‐Preusse, K., Potier, B., Ayciriex, S., Varin, J., Gautier, B., Djelti, F., Audrain, M., Dauphinot, L., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv268 · Cited by 122 · see citing works
Locus coeruleus at asymptomatic early and middle Braak stages of neurofibrillary tangle pathology
Andrés‐Benito, P., Fernández‐Dueñas, V., Carmona, M., Escobar, L. A., Torrejón-Escribano, B., Aso, E., Ciruela, F., & Ferrer, I. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12386 · Cited by 116 · see citing works
Synaptic Elimination in Neurological Disorders
Cardozo, P. L., de Lima, I. B. Q., Maciel, E. M. A., Silva, N. C., Dobránsky, T., & Ribeiro, F. M. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190603170511 · Cited by 113 · see citing works
Vinuesa, Á., Pomilio, C. J., Gregosa, A., Bentivegna, M., Presa, J., Bellotto, M., Saravia, F., & Beauquis, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.653651 · Cited by 111 · see citing works
Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders
Bhat, A., Ray, B., Mahalakshmi, A. M., Tuladhar, S., Nandakumar, D., Srinivasan, M., Essa, M. M., Chidambaram, S. B., Guillemin, G. J., & Sakharkar, M. K. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105078 · Cited by 107 · see citing works
Tau physiology and pathomechanisms in frontotemporal lobar degeneration
Bodea, L., Eckert, A., Ittner, L. M., Piguet, O., & Götz, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13600 · Cited by 104 · see citing works
Characteristics of Tau and Its Ligands in PET Imaging
Harada, R., Okamura, N., Furumoto, S., Tago, T., Yanai, K., Arai, H., & Kudo, Y. (2016) · Biomolecules · doi:10.3390/biom6010007 · Cited by 103 · see citing works
Selective alterations of neurons and circuits related to early memory loss in Alzheimer’s disease
Llorens-Martı́n, M., Blázquez‐Llorca, L., Benavides‐Piccione, R., Rábano, A., Hernández, F., Ávila, J., & DeFelipe, J. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00038 · Cited by 94 · see citing works
Self-citationMontero‐Crespo, M., Domínguez-Álvaro, M., Alonso‐Nanclares, L., DeFelipe, J., & Blázquez‐Llorca, L. (2020) · Brain · doi:10.1093/brain/awaa406 · Cited by 88 · see citing works
Self-citationThree-dimensional analysis of synapses in the transentorhinal cortex of Alzheimer’s disease patients
Domínguez-Álvaro, M., Montero-Crespo, M., Blazquez-Llorca, L., Insausti, R., DeFelipe, J., & Alonso-Nanclares, L. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0520-6 · Cited by 79 · see citing works
Self-citationMetabolomics and neuroanatomical evaluation of post-mortem changes in the hippocampus
González-Riaño, C., Tapia‐González, S., Garcı́a, A., Muñoz, A., DeFelipe, J., & Barbas, C. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1375-5 · Cited by 76 · see citing works
Self-citationIs sporadic Alzheimer′s disease a developmental disorder?
Arendt, T., Stieler, J., & Ueberham, U. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14036 · Cited by 75 · see citing works
Furcila, D., DeFelipe, J., & Alonso‐Nanclares, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180173 · Cited by 70 · see citing works
Self-citation27-Hydroxycholesterol Induces Aberrant Morphology and Synaptic Dysfunction in Hippocampal Neurons
Merino‐Serrais, P., Loera‐Valencia, R., Rodriguez‐Rodriguez, P., Parrado‐Fernández, C., Ismail, M. A. M., Maioli, S., Matute, E., Jimenez-Mateos, E. M., Björkhem, I., DeFelipe, J., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy274 · Cited by 71 · see citing works
Self-citationHippocampal Deficits in Amyloid-β-Related Rodent Models of Alzheimer’s Disease
Vyas, Y., Montgomery, J. M., & Cheyne, J. E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00266 · Cited by 66 · see citing works
Llorens-Martı́n, M., Jurado‐Arjona, J., Fuster-Matanzo, A., Hernández, F., Rábano, A., & Ávila, J. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.92 · Cited by 67 · see citing works
Self-citationGene expression parallels synaptic excitability and plasticity changes in Alzheimer’s disease
Saura, C. A., Parra‐Damas, A., & Enríquez-Barreto, L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00318 · Cited by 65 · see citing works
High plasticity of axonal pathology in Alzheimer’s disease mouse models
Blázquez‐Llorca, L., Valero-Freitag, S., Rodrigues, E. F., Merchán-Pérez, Á., Rodríguez, J., Dorostkar, M. M., DeFelipe, J., & Herms, J. W. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0415-y · Cited by 62 · see citing works
Self-citationImpaired plasticity of cortical dendritic spines in P301S tau transgenic mice
Hoffmann, N. A., Dorostkar, M. M., Blumenstock, S., Goedert, M., & Herms, J. W. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-82 · Cited by 64 · see citing works
Wang, Z., Liu, A., Yu, J., Wang, P., Bi, Y.-W., Xue, S., Zhang, J., Guo, H., & Zhang, W. (2023) · GeroScience · doi:10.1007/s11357-023-01041-8 · Cited by 61 · see citing works
Roscoe, R. F., Mactutus, C. F., & Booze, R. M. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9555-z · Cited by 56 · see citing works
Domínguez-Álvaro, M., Montero‐Crespo, M., Blázquez‐Llorca, L., DeFelipe, J., & Alonso‐Nanclares, L. (2019) · eNeuro · doi:10.1523/eneuro.0140-19.2019 · Cited by 64 · see citing works
Self-citationChakraborty, P., Dey, A., Gopalakrishnan, A. V., Swati, K., Ojha, S. K., Prakash, A., Kumar, D., Ambasta, R. K., Jha, N. K., Jha, S. K., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101838 · Cited by 58 · see citing works
Furcila, D., Domínguez-Álvaro, M., DeFelipe, J., & Alonso‐Nanclares, L. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00099 · Cited by 57 · see citing works
Self-citationDendritic spines are lost in clusters in Alzheimer’s disease
Mijalkov, M., Volpe, G., Fernaud-Espinosa, I., DeFelipe, J., Pereira, J. B., & Merino‐Serrais, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-91726-x · Cited by 55 · see citing works
Self-citationAlexander, C., Parsaee, A., & Vasefi, M. (2023) · Biology · doi:10.3390/biology12111453 · Cited by 51 · see citing works
Tau Mislocation in Glucocorticoid-Triggered Hippocampal Pathology
Pinheiro, S., Silva, J. M., Mota, C., Vaz‐Silva, J., Veloso, A., Pinto, V., Sousa, N., Cerqueira, J., & Sotiropoulos, I. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9356-2 · Cited by 43 · see citing works
Further understanding of tau phosphorylation: implications for therapy
Medina, M., & Avila, J. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1000864 · Cited by 41 · see citing works
Bertan, F., Wischhof, L., Sosulina, L., Mittag, M., Dalügge, D., Fornarelli, A., Gardoni, F., Marcello, E. E., Luca, M. D., Fuhrmann, M., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0584-2 · Cited by 41 · see citing works
Braak, H., & Del Tredici, K. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz123 · Cited by 40 · see citing works
High levels of 27-hydroxycholesterol results in synaptic plasticity alterations in the hippocampus
Loera‐Valencia, R., Vázquez‐Juárez, E., Muñoz, A., Gereñu, G., Gómez‐Galán, M., Lindskog, M., DeFelipe, J., Cedazo-Mı́nguez, Á., & Merino‐Serrais, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-83008-3 · Cited by 39 · see citing works
Self-citationThe ‘a, b, c’s of pretangle tau and their relation to aging and the risk of Alzheimer’s Disease
Harley, C. W., Walling, S. G., Yuan, Q., & Martin, G. M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.12.010 · Cited by 39 · see citing works
Martín‐Belmonte, A., Aguado, C., Alfaro‐Ruiz, R., Moreno‐Martínez, A. E., de la Ossa, L., Hernández, J. M., Buisson, A., Shigemoto, R., Fukazawa, Y., & Luján, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072459 · Cited by 38 · see citing works
mNos2Deletion and HumanNOS2Replacement in Alzheimer Disease Models
Colton, C. A., Wilson, J. G., Everhart, A. L., Wilcock, D. M., Puoliväli, J. T., Heikkinen, T., Oksman, J., Jääskeläinen, O., Lehtimäki, K. K., Laitinen, T., et al. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000094 · Cited by 37 · see citing works
Kulasiri, D., Khan, R., & Samarasinghe, S. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.300331 · Cited by 33 · see citing works
Ávila, J., Pallas‐Bazarra, N., Bolós, M., Sayas, C. L., & Hernández, F. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1131269 · Cited by 34 · see citing works
Dcf1 Triggers Dendritic Spine Formation and Facilitates Memory Acquisition
Liu, Q., Feng, R., Chen, Y., Luo, G., Huang, Y. X., Chen, L., Lin, R., Ding, Y., & Wen, T. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0349-6 · Cited by 32 · see citing works
Weston, P. S. J., Coath, W., Harris, M., Malone, I. B., Dickson, J. C., Aigbirhio, F. I., Cash, D. M., Zhang, H. G., & Schott, J. M. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13011 · Cited by 27 · see citing works
Jin, M., Wang, S., Gao, X., Zou, Z., Hirotsune, S., & Sun, L. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382231 · Cited by 27 · see citing works
Ablation of dynamin-related protein 1 promotes diabetes-induced synaptic injury in the hippocampus
Park, K. A., Lee, J. Y., Han, H. M., An, H. S., Jin, Z. H., Jeong, E. A., Kim, K. E., Shin, H. J., Lee, J., Kang, D., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03723-7 · Cited by 25 · see citing works
Diagnostic and prognostic biomarkers for HAND
McLaurin, K. A., Booze, R. M., & Mactutus, C. F. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-018-0705-6 · Cited by 25 · see citing works
Cyclosporine A (CsA) prevents synaptic impairment caused by truncated tau by caspase-3
Tapia-Monsalves, C., Olesen, M. A., Villavicencio-Tejo, F., & Quintanilla, R. A. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103861 · Cited by 24 · see citing works
Illes, S. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804279-3.00003-4 · Cited by 23 · see citing works
Koss, D. J., Dubini, M., Buchanan, H. M., Hull, C. E., & Platt, B. (2018) · Brain Research · doi:10.1016/j.brainres.2018.08.014 · Cited by 22 · see citing works
Targeting Tau to Treat Clinical Features of Huntington's Disease
Masnata, M., Salem, S., Jacquet, A. D. R., Anwer, M., & Cicchetti, F. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.580732 · Cited by 23 · see citing works
Trujillo‐Estrada, L., Vanderklish, P. W., Nguyen, M. M. T., Kuang, R. R., Nguyen, C., Huynh, E., da Cunha, C., Javonillo, D. I., Forner, S., Martini, A. C., et al. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01143-1 · Cited by 21 · see citing works
Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 21 · see citing works
Márquez‐Valadez, B., Rábano, A., & Llorens-Martı́n, M. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01431-7 · Cited by 20 · see citing works
Self-citationPallas‐Bazarra, N., Kastanauskaite, A., Ávila, J., DeFelipe, J., & Llorens-Martı́n, M. (2017) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2017.00018 · Cited by 20 · see citing works
Self-citationA Deep Learning-Based Workflow for Dendritic Spine Segmentation
Vidaurre-Gallart, I., Fernaud-Espinosa, I., Cosmin-Toader, N., Talavera-Martínez, L., Martín-Abadal, M., Benavides‐Piccione, R., González-Cid, Y., Pastor, L., DeFelipe, J., & García, M. (2022) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2022.817903 · Cited by 19 · see citing works
Self-citationPyramidal cell axon initial segment in Alzheimer´s disease
Antón‐Fernández, A., León‐Espinosa, G., DeFelipe, J., & Muñoz, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-12700-9 · Cited by 20 · see citing works
Self-citationBachmann, C., Tetzlaff, T., Duarte, R., & Morrison, A. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007790 · Cited by 18 · see citing works
Colom‐Cadena, M., Davies, C., Sirisi, S., Lee, J.-E., Simzer, E. M., Tzioras, M., Querol‐Vilaseca, M., Sánchez‐Aced, É., Chang, Y. Y., Holt, K., et al. (2023) · medRxiv · doi:10.1101/2023.03.15.23287268 · Cited by 19 · see citing works
Richardson, T. E., Walker, J. M., Farrell, K. W., Oliveira, T. G., White, C. L., & Crary, J. F. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02943-x · Cited by 21 · see citing works
Özdemir, Ç., Arslan, M., Küçük, A., Yığman, Z., & Dursun, A. D. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s405963 · Cited by 18 · see citing works
Stein-O’Brien, G., Palaganas, R. G., Meyer, E. M., Redding‐Ochoa, J., Pletniková, O., Guo, H., Bell, W. R., Troncoso, J. C., Huganir, R. L., & Morris, M. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115422 · Cited by 18 · see citing works
Braak, H., Mayer, B., Feldengut, S., Schön, M., & Tredici, K. D. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02862-x · Cited by 20 · see citing works
Suzuki, M., & Kimura, T. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.05.056 · Cited by 18 · see citing works
Impaired Synaptic Plasticity Mechanisms in Alzheimer’s Disease
Ebrahimi, R., Golzari, Z., Heidari‐Foroozan, M., Khosravi, A., Sharghi, S. G., Saleh, M., Salarvandian, S., & Esmaeilpour, K. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01712-9 · Cited by 19 · see citing works
RanBP9 overexpression accelerates loss of dendritic spines in a mouse model of Alzheimer's disease
Wang, R., Palavicini, J. P., Wang, H., Maiti, P., Bianchi, E., Xu, S., Lloyd, B. N., Dawson-Scully, K. D., Kang, D. E., & Lakshmana, M. K. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.029 · Cited by 17 · see citing works
Age-dependent changes in synaptic plasticity enhance tau oligomerization in the mouse hippocampus
Kimura, T., Suzuki, M., & Akagi, T. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0469-x · Cited by 17 · see citing works
Modelling the contributions to hyperexcitability in a mouse model of Alzheimer's disease
Mittag, M., Mediavilla, L., Remy, S., Cuntz, H., & Jedlička, P. (2023) · The Journal of Physiology · doi:10.1113/jp283401 · Cited by 19 · see citing works
DiI‐mediated analysis of presynaptic and postsynaptic structures in human postmortem brain tissue
Das, S. C., Chen, D., Callor, W. B., Christensen, E., Coon, H. H., & Williams, M. E. (2019) · The Journal of Comparative Neurology · doi:10.1002/cne.24722 · Cited by 13 · see citing works
Bertan, F., Wischhof, L., Sosulina, L., Mittag, M., Dalügge, D., Fornarelli, A., Gardoni, F., Marcello, E. E., Luca, M. D., Fuhrmann, M., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00605-x · Cited by 15 · see citing works
Structural changes of CA1 pyramidal neurons after stroke in the contralesional hippocampus
Merino‐Serrais, P., Plaza‐Alonso, S., Hellal, F., Valero-Freitag, S., Kastanauskaite, A., Plesnila, N., & DeFelipe, J. (2023) · Brain Pathology · doi:10.1111/bpa.13222 · Cited by 12 · see citing works
Self-citationMicrotubule Organization and Microtubule-Associated Proteins (MAPs)
Tortosa, E., Kapitein, L. C., & Hoogenraad, C. C. (2016) · Springer eBooks · doi:10.1007/978-4-431-56050-0_3 · Cited by 13 · see citing works
Braak, H., & Tredici, K. D. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_22 · Cited by 10 · see citing works
Emmerson, J. T., Malcolm, J. C., Carmo, S. D., Nguyen, P., Breuillaud, L., Martínez-Trujillo, J., & Cuello, A. C. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106317 · Cited by 11 · see citing works
Cabrera-Álvarez, J., Stefanovski, L., Martin, L., Susi, G., Maestú, F., & Ritter, P. (2024) · eNeuro · doi:10.1523/eneuro.0345-23.2023 · Cited by 11 · see citing works
Walker, C. K., Greathouse, K. M., Liu, E., Muhammad, H. M., Boros, B. D., Freeman, C. D., Seo, J. V., & Herskowitz, J. H. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.06.029 · Cited by 11 · see citing works
Phosphorylated tau in Alzheimer’s disease
Telser, J., Grossmann, K., Wohlwend, N., Risch, L., Saely, C. H., & Werner, P. (2023) · Advances in clinical chemistry · doi:10.1016/bs.acc.2023.05.001 · Cited by 11 · see citing works
Mak, E., Reid, R. I., Przybelski, S. A., Fought, A. J., Lesnick, T. G., Schwarz, C. G., Senjem, M. L., Raghavan, S., Vemuri, P., Jack, C. R., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00944-x · Cited by 13 · see citing works
Kong, Y., Zhang, S., Huang, L., Zhang, C., Xie, F., Zhang, Z., Huang, Q., Jiang, D., Li, J., Zhou, W., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.731114 · Cited by 11 · see citing works
Antón‐Fernández, A., Merchán‐Rubira, J., Ávila, J., Hernández, F., DeFelipe, J., & Muñoz, A. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170332 · Cited by 10 · see citing works
Self-citationSanchez-Todo, R., Mercadal, B., Lopez-Sola, E., Guasch-Morgades, M., Deco, G., & Ruffini, G. (2026) · Human Brain Mapping · doi:10.1002/hbm.70428 · Cited by 9 · see citing works
Nguyen, D. L., Okolicsanyi, R. K., & Haupt, L. M. (2024) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2024.103936 · Cited by 9 · see citing works
Li, K., Jiang, Y., Li, G., Liu, T., & Yang, Z. R. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00574 · Cited by 8 · see citing works
EuroTau: towing scientists to tau without tautology
Mudher, A. K., Brion, J., Ávila, J., Medina, M., & Buée, L. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0491-z · Cited by 7 · see citing works
Warling, A., Uchida, R., Shin, H., Dodelson, C., Garcia, M. E., Shea‐Shumsky, N. B., Svirsky, S. E., Pothast, M. J., Kelley, H., Schumann, C. M., et al. (2020) · The Journal of Comparative Neurology · doi:10.1002/cne.25022 · Cited by 6 · see citing works
Luján, R., Merchán-Pérez, Á., Soriano, J., Martín‐Belmonte, A., Aguado, C., Alfaro‐Ruiz, R., Moreno‐Martínez, A. E., & DeFelipe, J. (2021) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2021.781314 · Cited by 7 · see citing works
Self-citationTau Protein Modulates Perineuronal Extracellular Matrix Expression in the TauP301L-acan Mouse Model
Schmidt, S., Holzer, M., Arendt, T., Sonntag, M., & Morawski, M. (2022) · Biomolecules · doi:10.3390/biom12040505 · Cited by 6 · see citing works
- Authors
- Merino-Serrais, P., Benavides-Piccione, R., Blazquez-Llorca, L., Kastanauskaite, A., Rábano, A., Avila, J., & DeFelipe, J.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Fundacion Centro De Investigacion De Enfermedades Neurologicas (ES)
- Corresponding author
- DeFelipe, Javier
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-05-28
- Volume
- 136
- Issue
- 6
- Pages
- 1913-1928
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC3673457
- OpenAlex
- W2121418448
- Cited by
- 134
- References
- 91
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 6 · 2023: 15 · 2022: 10 · 2021: 13 · 2020: 17 · 2019: 8 · 2018: 7 · 2017: 16 · 2016: 8 · 2015: 10 · 2014: 10 · 2013: 2
- FWCI
- 6.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Brain (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by-nc)
- Funders
- Ministerio de Economía y Competitividad
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, tau phosphorylation, phosphorylated tau, dendritic spines, pyramidal neurons, neurofibrillary tangles, parahippocampal cortex, CA1, postsynaptic structures, cognitive impairment
- MeSH terms
- Alzheimer Disease, Cell Count, Cerebral Cortex, Humans, Phosphorylation, tau Proteins, Pyramidal Cells, Dendritic Spines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-02.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-02.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review